UNSPSC 85494667: Dilation of superior vena cava with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of superior vena cava with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 027V3DZ

UNSPSC 85494667 Dilation of superior vena cava with intraluminal device, percutaneous approach is a Commodity code that shows substantial mismatch between its nominal scope—a specific interventional medical procedure—and the actual state and local procurement activity recently tagged under it. The recent opportunities posted under this code include disability medical evaluations for public safety retirement applicants, surgical benefit carve-out programs for municipal employee health plans, occupational medical surveillance for transportation workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing. None of these solicitations involve vena cava dilation procedures or interventional cardiology devices. The issuing bodies span city retirement offices, municipal human resources departments, state transportation agencies, county juvenile justice departments, county health administrators, and regional health systems—a mix typical of state and local government healthcare procurement broadly, but not reflective of procurement specifically targeting interventional procedures or medical devices.

The geographic spread of recent activity includes Arizona (City of Phoenix), California (City of Long Beach and County of Santa Clara), Washington State (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County), with no clear concentration in any single jurisdiction or region. Because the code's nominal definition does not align with the work actually being solicited under it in recent months, the code does not provide a reliable signal for business development targeting state and local procurement of vena cava dilation services or related interventional medical devices. Firms pursuing opportunities in this UNSPSC code should treat the tagging as a taxonomy misclassification and instead monitor representative RFPs and RFQs directly—such as the City of Phoenix's independent medical evaluation RFP (due October 16, 2026) or the Washington State Ferries occupational medical surveillance RFP (due October 9, 2026)—to confirm actual scope alignment before investing proposal resources.